Patents Assigned to University
  • Patent number: 10302424
    Abstract: Motion contrast depth scanning is disclosed herein. A disclosed example apparatus includes an illumination source that is to provide at least one of spatial or temporal changes to light emitted from the illumination source to a scene. The example apparatus also includes a motion contrast sensor, where pixels of the motion contrast sensor are to detect changes corresponding to the scene, and where the motion contrast sensor is to report measurements when a pixel change exceeds a threshold. The example apparatus further includes a processor to determine at least one of a reflectance, a depth, or movement of the scene based on the reported measurements by the motion contrast sensor.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: May 28, 2019
    Assignee: Northwestern University
    Inventors: Oliver Strider Cossairt, Nathan Matsuda
  • Patent number: 10299670
    Abstract: The self-retaining nasal septum retractor includes two pivotally attached arms having handles on one end and speculum blades on the opposing end. The speculum blades are adjustably connected to the arms through pivoting joints. A user can adjust the vertical displacement and angular relation between the speculum blades and the arms to fit different patient septal/nasal structures. A self-retaining mechanism allows a user to lock the retractor in a retracted position, freeing up a hand of the user for other surgical tasks.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: May 28, 2019
    Assignee: King Saud University
    Inventor: Ibrahim Ali Sumaily
  • Patent number: 10301608
    Abstract: Variants of phosphotriesterase have been created that exhibit enhanced hydrolysis of V-type and G-type nerve agents over wild-type phosphotriesterase. V- and G-type nerve agents have an SP and RP enantiomer. The SP enantiomers are more toxic. V-type nerve agents are among the most toxic substances known. Variants of phosphotriesterase can prefer to hydrolyze one enantiomer of VX over the other enantiomer.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: May 28, 2019
    Assignee: The Texas A&M University System
    Inventors: Frank M. Raushel, Andrew N. Bigley
  • Patent number: 10300100
    Abstract: The extract of Vicia faba beans is prepared by soaking beans in distilled water overnight and then boiling in a water bath to reduce the volume of aqueous extract, which is then homogenized and filtered. The filtrate is concentrated to a smaller volume, lyophilized, and powdered. The lyophilized powder is extracted with hexane to remove oils and lipids. The oil-free lyophilized powder is dissolved in ethanol solvent and extracted for eight hours under reflux, and filtered. The volume of ethanol is reduced by a rotary evaporator, and a first off-white precipitate (sample A-1) is collected, washed with ethanol, and dried at 80° C. Mass spectrometry shows a molecular weight of 200.16447 g mol?1, and an empirical formula of C9H16N2O3 is assigned. Intraperitoneal injection of mice with 50 mg/kg of A-1 twenty minutes prior to injection with strychnine protected the mice from strychnine-induced convulsions to the same extent as phenobarbitone (phenobarbital).
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: May 28, 2019
    Assignee: King Saud University
    Inventors: Mutasim Ibrahim Khalil, Mustafa Abdalla Mohamed Salih, Ali Ahmed Mustafa Ali
  • Patent number: 10300037
    Abstract: This invention is directed to substituted acylanilide compounds and uses thereof in treating muscular dystrophies such as Duchenne muscular dystrophy and Becker muscular dystrophy and in improving or preserving lung function and cardiac function in a subject suffering from Duchenne muscular dystrophy.
    Type: Grant
    Filed: October 18, 2017
    Date of Patent: May 28, 2019
    Assignee: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: James T. Dalton, Thamarai Ponnusamy, Ramesh Narayanan
  • Patent number: 10300299
    Abstract: The present invention relates to methods for treating cell proliferation disorders comprising: (1) administering to the subject at least one activatable pharmaceutical agent that is capable of activation by a simultaneous two photon absorption event and of effecting a predetermined cellular change when activated; (2) administering at least one plasmonics-active agent to the subject, and (3) applying an initiation energy from an initiation energy source to the subject, wherein the plasmonics-active agent enhances or modifies the applied initiation energy, such that the enhanced or modified initiation energy activates the activatable pharmaceutical agent by the simultaneous two photon absorption event in situ, thus causing the predetermined cellular change to occur, wherein said predetermined cellular change treats the cell proliferation related disorder; and the use of plasmonics enhanced photospectral therapy (PEPST) and exiton-plasmon enhanced phototherapy (EPEP) in the treatment of various cell prolifer
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: May 28, 2019
    Assignees: Immunolight, LLC, Duke University
    Inventors: Frederic A. Bourke, Jr., Tuan Vo-Dinh
  • Patent number: 10301218
    Abstract: The low cement content strain-hardening cementitious composite is cement with a natural pozzolan replacing a significant portion of the Portland cement therein. The strain-hardening cementitious composite includes a mixture of cement, fly ash, sand, a polycarboxylic ether-based superplasticizer, and reinforcing polyvinyl alcohol fibers. The mixture is formed with a low content of Portland cement (6-12 wt %) and with ground scoria as the natural pozzolan (5-20%). The sand forms at least 22 wt % of the strain-hardening cementitious composite and is preferably in the form of sieved dune sand, having a silicon dioxide concentration of between approximately 80 and 90 wt %, and a feldspar concentration of between approximately 10 and 20 wt %. The dune sand is sieved such that the sand grains have a median diameter of less than or equal to approximately 300 ?m, and preferably have a median diameter of approximately 200 ?m.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: May 28, 2019
    Assignee: King Saud University
    Inventors: Mohammad Iqbal Khan, Galal Fares
  • Patent number: 10301204
    Abstract: A method of removing organic carbon in biological wastewater treatment includes the steps of: (a) oxidizing organic carbon to carbon dioxide with elemental sulfur as an electron carrier, and reducing the elemental sulfur to sulfide; (b) oxidizing the sulfide to elemental sulfur by recycled nitrate through controlling one or more of a recycling ratio to maintain an oxidation reduction potential (ORP) within the range of ?360 mv to ?420 mv, using an auto ORP controller; (c) recycling the elemental sulfur formed during oxidation of the sulfide back to the oxidation of the organic carbon; and (d) oxidizing ammonium to nitrate then partially recycled back for sulfide oxidation.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: May 28, 2019
    Assignee: THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Guanghao Chen, Feng Jiang, Ho Kwong Chui
  • Patent number: 10300313
    Abstract: A method and devices are described, in which a transformable fiber at a first crystal structure is shaped from its pre-determined configuration into a new shaped configuration. The new shaped configuration of the transformable fiber is inserted into a cavity of a heat and fire protective item. The new shaped configuration of the transformable fiber is heated to above its transformation temperature to a second crystal structure. The heating transforms the new shaped configuration to its pre-determined configuration, wherein the pre-determined configuration forms an air pocket within the heat and fire protective item. The transformable fiber is cooled below its transformation temperature to revert the transformable fiber back to the new shaped configuration at the first crystal structure.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: May 28, 2019
    Assignee: UNIVERSITY OF MARYLAND, COLLEGE PARK
    Inventors: Amr M. Baz, Marino diMarzo
  • Patent number: 10306171
    Abstract: An analog-digital converter may include: an analog-digital converter comprising: a ramp signal selection unit suitable for receiving ramp signals having different offsets, and sequentially selecting one of the ramp signals according to a preset order; a comparison unit suitable for comparing the magnitudes of the selected ramp signal with a pixel signal, and outputting a comparison signal according to the comparison result; and a counting unit suitable for counting the number of clocks of a clock signal until the comparison signal transitions, and outputting a count signal based on the count when the comparison signal transitions.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: May 28, 2019
    Assignees: SK hynix Inc., Industry-University Cooperation Foundation Hanyang University
    Inventors: Sang Dong Yoo, Min Kyu Kim, Jun Bo Shim
  • Patent number: 10302245
    Abstract: In one aspect, kits for constructing an apparatus are described herein which, in some embodiments, can demonstrate desirable modularity, adjustability, and reconfigurability. A kit for constructing an apparatus described herein comprises a plurality of modular blocks and fastening pins and coupling pins for connecting the modular blocks to one another. A modular block comprises a first face having one or more first apertures for receiving fastening pins and an adjacent second face having one or more second apertures for receiving coupling pins. A fastening pin comprises a sidewall aperture for receiving a coupling pin.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: May 28, 2019
    Assignee: THE UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE
    Inventors: Stuart T. Smith, Stephen C. Howard
  • Patent number: 10301587
    Abstract: Disclosed are methods and systems for subnanosecond rise time high voltage (HV) electric pulse delivery to biological loads. The system includes an imaging device and monitoring apparatus used for bio-photonic studies of pulse induced intracellular effects. The system further features a custom fabricated microscope slide having micro-machined electrodes. A printed circuit board to interface the pulse generator to the micro-machined glass slide having the cell solution is disclosed. An low-parasitic electronic setup to interface with avalanche transistor-switched pulse generation system is also disclosed. The pc-board and the slide are configured to match the output impedance of the pulse generator which minimizes reflection back into the pulse generator, and minimizes distortion of the pulse shape and pulse parameters. The pc-board further includes a high bandwidth voltage divider for real-time monitoring of pulses delivered to the cell solutions.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: May 28, 2019
    Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Pavitra Krishnaswamy, Andras Kuthi
  • Patent number: 10301597
    Abstract: The present invention relates to the production of cell cultures and tissues from undifferentiated pluripotent stem cells using three-dimensional biomimetic materials. The resultant cell cultures or tissues can be used in any of a number of protocols including testing chemicals, compounds, and drugs. Further, the methods and compositions of the present invention further provide viable cell sources and novel cell delivery platforms that allow for replacement of diseased tissue and engraftment of new cardiomyocytes from a readily available in vitro source. The present invention includes novel methods required for the successful production of cell cultures and tissues, systems and components used for the same, and methods of using the resultant cell and tissue compositions.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: May 28, 2019
    Assignee: Auburn University
    Inventors: Elizabeth A. Lipke, Petra Kerscher, Alexander J. Hodge
  • Patent number: 10301543
    Abstract: Embodiments of the present disclosure provide for methods of making quantum dots (QDs) (passivated or unpassivated) using a continuous flow process, systems for making QDs using a continuous flow process, and the like. In one or more embodiments, the QDs produced using embodiments of the present disclosure can be used in solar photovoltaic cells, bio-imaging, IR emitters, or LEDs.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: May 28, 2019
    Assignee: KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Osman M. Bakr, Jun Pan, Ala'a El-Ballouli, Kristian Rahbek Knudsen, Ahmed L. Abdelhady
  • Patent number: 10304217
    Abstract: An image is reconstructed based upon a filtered backprojection (FBP) technique using a reconstruction filter which is customized or shaped by parameters including a weight value that is determined for weighing projection data according to a predetermined noise model. The weight value is determined based upon rays or views in the projection data. A regularization term is also combined with the noise-weighted FBP.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: May 28, 2019
    Assignees: TOSHIBA MEDICAL SYSTEMS CORPORATION, UNIVERSITY OF UTAH REASEARCH FOUNDATION
    Inventors: Gengsheng L. Zeng, Alexander Zamyatin
  • Patent number: 10306135
    Abstract: There is set forth herein a system including a camera device. In one embodiment the system is operative to perform image processing for detection of an event involving a human subject. There is set forth herein in one embodiment, a camera equipped system employed for fall detection.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: May 28, 2019
    Assignee: Syracuse University
    Inventors: Senem Velipasalar, Mauricio Casares, Akhan Almagambetov
  • Patent number: 10306297
    Abstract: A method of operating a transmitting apparatus in a multimedia system is provided. The method includes transmitting a data unit of a multimedia service including event information related to an event, wherein the event includes notification to an application, the notification indicating that an action is to be taken.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: May 28, 2019
    Assignees: Samsung Electronics Co., Ltd., KYONGGI UNIVERSITY INDUSTRY & ACADEMIA COOPERATION FOUNDATION
    Inventors: Hyun-Koo Yang, Byoung-Dai Lee, Young-Sun Ryu
  • Patent number: 10300103
    Abstract: A lactic acid bacterium-containing composition including a lactic acid bacterium having a human papillomavirus (HPV) E7 protein-derived polypeptide on a surface thereof, wherein the HPV E7 protein-derived polypeptide is included in an amount of 0.03 ?g to 1.0 ?g per 1×108 lactic acid bacteria; a therapeutic oral pharmaceutical composition for at least one of an HPV infectious disease and an HPV-associated tumor which includes the lactic acid bacterium-containing composition; and a mucosal immunity-inducing agent which includes the lactic acid bacterium-containing composition.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: May 28, 2019
    Assignees: The University of Tokyo, Japan Health Sciences Foundation
    Inventors: Kei Kawana, Shizunobu Igimi
  • Patent number: 10302566
    Abstract: A method evaluates the mobility of a polymer composition in a high-temperature region of 150° C. or above. The method for evaluating a physical property of a polymer composition, the method comprising the steps of: obtaining a thin film sample which is formed on a substrate and which comprises: a fluorescent probe including a fluorescent rare earth complex having a melting point of 200° C. or higher; and a target polymer composition; and obtaining a relationship between a temperature and a fluorescent characteristic of the thin film.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: May 28, 2019
    Assignees: Kyushu University, Fuji Electric Co., Ltd.
    Inventors: Keiji Tanaka, Daisuke Kawaguchi, Atsuomi Shundo, Mika Aoki, Tatsuya Ganbe, Nobuyuki Sekine, Kenji Okamoto
  • Patent number: 10300284
    Abstract: Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: May 28, 2019
    Assignees: LivaNova USA, Inc., East Tennessee State University
    Inventors: Bruce H. KenKnight, Jeffrey L. Ardell, Imad Libbus, Badri Amurthur